What You Should Know:
– A new report from KLAS provides not only a much-needed update on the breadth of structured reporting adoption but also a first look at the depth of adoption since actual physician use is the only way to drive outcomes.
– While the market hasn’t reached the structured reporting tipping point yet, physician adoption is driving progress and generating value. This study also shares details on the hemodynamics experience (both overall satisfaction and important trends).
Structured Reporting Adoption and Healthcare
Each year, KLAS interviews thousands of healthcare professionals about the IT products and services their organizations use. These interviews are conducted using a standard quantitative evaluation, and the scores and commentary collected are shared in reports like this one and online in real time so that other providers and IT professionals can benefit from their peers’ experiences. To supplement the data gathered with this standard evaluation, KLAS also creates various supplemental evaluations that target a subset of KLAS’ overall sampling and delve deeper into the most pressing questions facing healthcare technology today.
The data in this report comes from both evaluation types and was collected over the last 12 months- the key findings and trends are listed as follows:
1. Change Healthcare and IBM Pave the Way For Adoption: Change Healthcare continues to lead in adoption of structured reporting. Users appreciate the reports’ organization and simple display, and strong usability has driven many clinicians to expand their use. Customization is a common need—clients note Change Healthcare has been making progress in this area, especially for echo (adult and pediatric) and vascular. Higher adoption and satisfaction are hampered by the continued need for manual input as well as nickel-and-diming for training, licenses, and hardware maintenance. IBM Watson Health continues to generate strong adoption and satisfaction. Across modules, IBM receives consistently positive ratings, with almost no customers reporting dissatisfaction. The technology meets customer needs and effectively drives outcomes; further development has been slow and has lessened clients’ enthusiasm.
2. Epic’s Adoption Grows as Deep Adopters Leave LUMDEX: Between 2016 and 2020, Epic saw the biggest adoption increase compared to other vendors, most notably in nuclear and vascular imaging, where manual extraction has been reduced. Customers who dedicate time and money to build out Cupid post-deployment increasingly feel that the product is starting to live up to their expectations due to organizations’ own internal efforts to drive progress. Customers commonly use Cupid for scheduling and registry reporting and then fill gaps with other vendors’ structured reporting tools—Epic respondents are about three times more likely to fill gaps than other customer bases. Epic lacks robust structured reporting for pediatric imaging (cath and echo), and EP adoption has been slow. These are the areas most commonly supplemented with non-Epic solutions because of Epic’s slower development progress and the expense required to build out structured reporting modules in Cupid. Customers don’t feel LUMEDX has improved their structured reporting in recent years, and many customers say they are more frustrated than ever. Poor training, declining phone and web support, and a perceived lack of development result in LUMEDX seeing higher-than-average customer turnover and few new sales. Just over one-third of respondents say LUMEDX is not part of their long-term plans, including several of the vendor’s deepest adopters. Many of LUMEDX’s past customers with deeper adoption left for other solutions they felt were more functional and on a better development trajectory.
3. Fujifilm, INFINITT, Siemens Customers Increase Adoption: Fujifilm has seen notable growth in EP structured reporting adoption and maintains high adoption in echo and cath. This is driven by a reliable product and strong integration(the latter a significant improvement in the last year). Fujifilm is held back from broader adoption by development, generally perceived as slow. Clients are not always kept in the loop about the development strategy. This creates a split between customers—a significant portion say Fuji has not proactively shared future plans; others who have insight into planned development are excited about expanded functionality and improvements. Training is another adoption barrier. Multiple customers say they didn’t get enough training or it wasn’t helpful to end users; this hurts energy to deploy new modules and physician willingness to use already-deployed modules. INFINITT, a newer market player with a smaller cardiology customer base, performs well and has improved their offering year over year, leading to deeper adoption. In past years, adoption was low outside echo, but INFINITT has made significant progress in pediatric (echo and cath), EP, and vascular imaging. This is driven by strong clinical usability (e.g., few clicks) and INFINITT’s track record for keeping promises of new functionality. Customers rarely run into downtime or bugs and report that data capture is accurate and efficient. Siemens’ small, loyal customer base is doing more with their vendor after a period of middle-of-the- road performance, making progress with a product they describe as reliable and steady.
4. GE Healthcare and Philips Experience More Migration to Newer Platforms: GE Healthcare’s new platform, Centricity Cardiology Enterprise Solution, is less broadly or deeply deployed than most other solutions. However, it receives high early ratings from customers—currently, it has the highest overall score of measured solutions. This represents significant improvement from the older DMS platform. Client implementation and training experiences have been mostly positive, supported by expert staff who are highly knowledgeable in cardiology. Ease of use has improved, bolstering depth of adoption for some respondents. Customers are optimistic about the potential of improved usability and functionality to drive significant adoption growth. Philips, once a leader in structured reporting adoption, has seen adoption rates drop since 2016 amid the transition from Xcelera to IntelliSpace. While IntelliSpace took a while to gain cardiology momentum, the tide has begun turning. IntelliSpace clients struggle to get back to their prior state with Xcelera and adopt additional modules. Respondents feel Philips’ resources and execution are insufficient to help drive successful implementation; this sentiment is particularly common among larger organizations. Above-average adoption rates for vascular and pediatric echo are a bright spot.
